T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary

T2 Biosystems

07/08/2023 23:05

* T2 Biosystems Inc  TTOO.OQ  reported a quarterly adjusted
loss
of 8 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 27 cents per share.
    * Revenue fell 66.8% to $1.96 million from a year ago;
analysts
expected $2.03 million. 
    * T2 Biosystems Inc's reported EPS for the quarter was a
loss of 8
cents​.
    * The mean earnings estimate of analysts had risen by
about 67.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * T2 Biosystems Inc shares had risen by 254.1% this
quarter and
lost 82.4% so far this year.
    * The company reported a quarterly loss of $6.35 million.
    * Wall Street's median 12-month price target for T2
Biosystems Inc
is $0.10 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:05 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.27          -0.08          Beat
 Mar. 31 2023      -1.20          -1.32          Missed
 Dec. 31 2022      -1.70          -1.41          Beat
 Sep. 30 2022      -2.04          -2.95          Missed